Arcutis Biotherapeutics, Inc.· ARQT

🇺🇸 US · MidBroad USNASDAQ

HealthcareBiotechnologyWebsite

Price: $26.03
Day: +0.35%
Mkt Cap: $3.26B
52W Range: $13.70 – $31.77
Volume: 1.23M
Beta: 1.53

D55D FrameworkQuarterly Data

Holdings Analysis

Insider activity, institutional flows, and fund ownership.

Blog

stockoscope.com

Arcutis Biotherapeutics, Inc.

ARQT|Healthcare|Biotechnology

Current price: $26

Smart Money

Dimension 5 of 5

Insider Activity, Q3 2026

Latest scored quarter, net flow, and top transactions by value

Net dollar flow-$127.3K

Net share flow-4.7K

Purchases0 ($0)

Sales1 ($127.3K)

Top Notable Transactions

Insider

Type

Value

Date

ORBIMED ADVISORS LLC

Sale

$6.5M

Jun 24

Heron Patrick J

Purchase

$5.0M

Aug 5

Frazier Life Sciences VIII, L.P.

Purchase

$5.0M

Aug 5

Institutional Ownership, Q1 2026

Ownership share, position changes, share flow, and top holders

Ownership102.2%

13F share flow-20.3%

Investors holding277

+187 adding-142 reducing

145

New 42Inc 145Red 87Closed 55

Top Institutional Holders

Institution

Value

Change

SUVRETTA CAPITAL MANAGEMENT, LLC

$290.4M

+2.5%

FRAZIER LIFE SCIENCES MANAGEMENT, L.P.

$232.6M

-0.5%

BLACKROCK, INC.

$216.8M

+0.6%

RUBRIC CAPITAL MANAGEMENT LP

$194.9M

-0.5%

ETF & Mutual Fund Activity, Q2 2026

Latest meaningful quarter: fund-by-fund buying / unchanged / selling

Funds reporting104

Total shares held21.9M

Share flow-12.5%

31 buying25 selling

Buying 31Unchanged 48Selling 25

Top Fund Holders

Fund

Weight

Change

FIDELITY MT VERNON STREET TRUST

584.5K

1.69%

Fidelity Central Investment Portfolios LLC

292.9K

1.61%

NEUBERGER BERMAN EQUITY FUNDS

162.5K

0.98%

VALIC Co I

156.9K

0.06%

-9.1K

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore ARQT on stockoscope.com→

Generated August 5, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

Smart Money Sentiment

ARQT Smart Money Sentiment Score

A weighted 1-5 sentiment score across three smart money signals.

Smart Money

3.4/5

Neutral

Weighted across 3 components

Component Breakdown (3 of 3 available)

Insider Activity

40% weight

Institutional Flow

50% weight

+36

Fund Flow

10% weight

+25

Overall Smart Money sentiment of 3.4/5 (Neutral) based on a weighted combination of 3 components. Insider activity uses a relative-baseline comparison against the stock's own history; institutional flow tracks position momentum and 13F share changes; fund flow measures ETF / mutual-fund buying vs selling. Higher scores indicate stronger bullish sentiment from professional investors.Last updated August 4, 2026.

Insider Trading Activity

Insider trading analysis comparing the latest quarter against the stock's own historical baseline.

Insider Activity for ARQT

Net insider share flow by quarter (C-suite & director purchases minus sales)

Neutral

Routine insider selling in Q3 2026

1 sale totaling $127.3K (4.7K shares)

Share volume is well below the historical pace (0.0x average), insiders are holding more

Buying seen in 2 of 7 quarters

Steady selling pace across recent quarters

Notable Recent Transactions, ARQT

Top 8 highest-value recent insider trades

ORBIMED ADVISORS LLC

Insider

Sell

306,027 shares at $21.31

Jun 24, 2022$6.52M

Heron Patrick J

Director

Buy

250,000 shares at $20.00

Aug 5, 2022$5.00M

Frazier Life Sciences VIII, L.P.

Insider

Buy

250,000 shares at $20.00

Aug 5, 2022$5.00M

Watanabe Todd

Director

Sell

48,945 shares at $30.36

Nov 24, 2025$1.49M

Watanabe Todd

Director

Sell

40,000 shares at $25.03

Oct 28, 2025$1.00M

Leonard Keith R

Director

Sell

39,272 shares at $25.39

Mar 2, 2026$997.19K

Watanabe Todd

Director

Sell

36,281 shares at $25.16

Mar 2, 2026$912.85K

Krishnamohan Neha

Director

Sell

39,272 shares at $23.19

Nov 13, 2025$910.70K

Institutional Ownership Analysis

Institutional ownership analysis with position momentum, 13F share flow, and ownership percentage trends.

Institutional Ownership Over Time for ARQT

Total dollar value invested by institutions each quarter

Bullish Signal

Institutions accumulating in Q1 2026

102.2% institutional ownership

Slight accumulation: 187 adding vs 142 reducing

13F shares increased by 2.3%, a notable change

Momentum weakening from prior quarter

Position Changes

Q2 2026: how are institutions adjusting their positions?

+23 growing-243 shrinkingNet: -220

219

New (4)

Increased (19)

Reduced (24)

Closed (219)

Top Institutional Holders, ARQT

Largest 8 institutional positions by ownership percentage as of Q2 2026

JENNISON ASSOCIATES LLC

4.2M

$110.6M

Ownership

3.26%

-15.3%

PERPETUAL LTD

1.1M

$29.1M

Ownership

0.86%

+22.0%

ABRDN PLC

1.1M

$28.8M

Ownership

0.85%

+70.3%

FISHMAN JAY A LTD/MI

595.0K

$15.6M

Ownership

0.46%

+5.0%

PEREGRINE CAPITAL MANAGEMENT LLC

291.4K

$7.6M

Ownership

0.23%

-4.8%

WALLEYE CAPITAL LLC

260.0K

$6.8M

Ownership

0.20%

+415.3%

PICTET ASSET MANAGEMENT HOLDING SA

200.3K

$5.4M

Ownership

0.15%

+45.0%

KORNITZER CAPITAL MANAGEMENT INC /KS

199.7K

$5.2M

Ownership

0.15%

+13.5%

ETF and Mutual Fund Holdings

ETF and mutual fund activity breakdown showing buying vs selling funds, top fund holders, and detailed holdings.

Fund Activity

Q2 2026: 104 ETFs and mutual funds reporting

31 buying25 sellingNet: +6

Buying (31)

Unchanged (48)

Selling (25)

Bullish Signal

Funds accumulating in Q2 2026

104 ETFs and mutual funds reporting

31 buying vs 25 selling (balanced)

Top Fund Holders, ARQT

Largest 8 ETF and mutual fund positions by shares held as of latest filing

FIDELITY MT VERNON STREET TRUST

584.5K

Weight

1.69%

No change

Fidelity Central Investment Portfolios LLC

292.9K

Weight

1.61%

No change

NEUBERGER BERMAN EQUITY FUNDS

162.5K

Weight

0.98%

No change

VALIC Co I

156.9K

Weight

0.06%

Decreased

John Hancock Funds II

151.9K

Weight

0.00%

No change

RBB FUND, INC.

79.2K

Weight

0.05%

No change

Goldman Sachs ETF Trust

74.4K

Weight

0.05%

Increased

Federated Hermes ETF Trust

70.0K

Weight

4.76%

Increased

Arcutis Biotherapeutics, Inc.· ARQT

Holdings Analysis

Insider Trading Activity

1.3Transaction History232Real market purchases and sales onlyShow All Types

Institutional Ownership Analysis

2.4Detailed Holdings79Most recent institutional positions with changes and valuations

ETF and Mutual Fund Holdings

3.3Fund Holdings Details25Most recent ETF and mutual fund holdings with share counts and weights

Search stocks

Holdings Analysis

Insider Trading Activity

1.3Transaction History232Real market purchases and sales onlyShow All Types

Institutional Ownership Analysis

2.4Detailed Holdings79Most recent institutional positions with changes and valuations

ETF and Mutual Fund Holdings

3.3Fund Holdings Details25Most recent ETF and mutual fund holdings with share counts and weights